Also Read: Weight Loss Supplements Market Analysis & Forecast for 2025-2032 Analysts View The global anti-obesity drug industry is set to experience strong growth, owing to rising prevalence of obesity, escalating health and wellness awareness, growing popularity of combination therapies, and advancements in new drug formulations, said a senior CMI analyst
Ozempic produces similar glycemic benefits, which makes sense given that diabetes was its original approved indication
Researchers are evaluating whether these changes may contribute to broader improvements in metabolic health
Tarasub N, Tarasub C,Devakul Na Ayutthaya W
However, when prescribed for weight loss, insurance coverage tends to be less consistent, as weight loss medications like Wegovy are not universally covered